Wilson, Peter W.F.

Intermittent Claudication: A Risk Profile From The Framingham Heart Study

Murabito, J. M., D’Agostino, R. B., Silbershatz, H., & Wilson, P. W. F. (1997) · Circulation

Peripheral Artery Disease ManagementCardiovascular Health and Risk Factors

Cited by 696

Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease: The Framingham Heart Study

Schaefer, E. J., Bongard, V., Beiser, A. S., Lamon-Fava, S., Robins, S. J., Au, R., Tucker, K. L., Kyle, D. J., Wilson, P. W. F., & Wolf, P. A. (2006) · Archives of Neurology

Fatty Acid Research and HealthDementia and Cognitive Impairment Research

Cited by 686

The Polygenic and Monogenic Basis of Blood Traits and Diseases

Vuckovic, D., Bao, E. L., Akbari, P., Lareau, C. A., Mousas, A., Jiang, T., Chen, M.-H., Raffield, L. M., Tardaguila, M., Huffman, J. E., et al. (2020) · Cell

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 671

Parental transmission of type 2 diabetes: the Framingham Offspring Study

Meigs, J. B., Cupples, L. A., & Wilson, P. W. (2000) · Diabetes

Diabetes, Cardiovascular Risks, and LipoproteinsGenetic Associations and Epidemiology

Cited by 666

C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study

Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. F. (2004) · Circulation

Adipokines, Inflammation, and Metabolic DiseasesLipoproteins and Cardiovascular Health

Cited by 664

Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations

Chen, M.-H., Raffield, L. M., Mousas, A., Sakaue, S., Huffman, J. E., Moscati, A., Trivedi, B., Jiang, T., Akbari, P., Vuckovic, D., et al. (2020) · Cell

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 661

Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?

Ridker, P. M., Wilson, P. W. F., & Grundy, S. M. (2004) · Circulation

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 645

Clinical utility of different lipid measures for prediction of coronary heart disease in men and women

Ingelsson, E., Schaefer, E. J., Contois, J. H., McNamara, J. R., Sullivan, L., Keyes, M. J., Pencina, M. J., Schoonmaker, C., Wilson, P. W. F., D’Agostino, R. B., et al. (2007) · JAMA

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 608

Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study

McKeown, N. M., Meigs, J. B., Liu, S., Wilson, P. W., & Jacques, P. F. (2002) · The American Journal of Clinical Nutrition

Food composition and propertiesNutritional Studies and Diet

Cited by 574

Framingham risk score and prediction of lifetime risk for coronary heart disease

Lloyd-Jones, D. M., Wilson, P. W. F., Larson, M. G., Beiser, A., Leip, E. P., D'Agostino, R. B., & Levy, D. (2004) · The American Journal of Cardiology

Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors

Cited by 566

Apolipoprotein E Alleles and Risk of Coronary Disease: A Meta-analysis

Wilson, P. W. F., Schaefer, E. J., Larson, M. G., & Ordovas, J. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 539

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association

Skulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation

Fatty Acid Research and HealthLipid metabolism and disorders

Cited by 512

Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study

Rutter, M. K., Parise, H., Benjamin, E. J., Levy, D., Larson, M. G., Meigs, J. B., Nesto, R. W., Wilson, P. W. F., & Vasan, R. S. (2003) · Circulation

Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 511

Fasting and Postchallenge Glycemia and Cardiovascular Disease Risk

Meigs, J. B., Nathan, D. M., D’Agostino, R. B., & Wilson, P. W. F. (2002) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 509

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Cavender, M. A., Steg, P. G., Smith, S. C., Eagle, K., Ohman, E. M., Goto, S., Kuder, J., Im, K., Wilson, P. W. F., & Bhatt, D. L. (2015) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

Cited by 501

Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study

Vasan, R. S., Benjamin, E. J., Larson, M. G., Leip, E. P., Wang, T. J., Wilson, P. W. F., & Levy, D. (2002) · JAMA

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 493

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

Wilson, P. W. F. (1994) · JAMA

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 468

Beyond Established and Novel Risk Factors: Lifestyle Risk Factors for Cardiovascular Disease

Mozaffarian, D., Wilson, P. W. F., & Kannel, W. B. (2008) · Circulation

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 456

Monocyte Cytokine Production in an Elderly Population: Effect of Age and Inflammation

Roubenoff, R., Harris, T. B., Abad, L. W., Wilson, P. W. F., Dallal, G. E., & Dinarello, C. A. (1998) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences

Adipokines, Inflammation, and Metabolic DiseasesImmune Response and Inflammation

Cited by 418

Sudden coronary death in women

Kannel, W. B., Wilson, P. W. F., D’Agostino, R. B., & Cobb, J. (1998) · American Heart Journal

Cardiac electrophysiology and arrhythmiasCardiac Health and Mental Health

Cited by 417

NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study

Elias, P. K., Elias, M. F., D'Agostino, R. B., Cupples, L. A., Wilson, P. W., Silbershatz, H., & Wolf, P. A. (1997) · Diabetes Care

Dementia and Cognitive Impairment ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 368

Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: The HEART2D trial

Raz, I., Wilson, P. W. F., Strojek, K., Kowalska, I., Bozikov, V., Gitt, A. K., Jermendy, G., Campaigne, B. N., Kerr, L., Milicevic, Z., et al. (2009) · Diabetes Care

Diabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patients

Cited by 351

Apolipoprotein E element 4 association with dementia in a population-based study: The Framingham Study

Myers, R. H., Schaefer, E. J., Wilson, P. W. F., D'Agostino, R., Ordovas, J. M., Espino, A., Au, R., White, R. F., Knoefel, J. E., Cobb, J. L., et al. (1996) · Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 346

Sex Differences in the Use of Statins in Community Practice: Patient and Provider Assessment of Lipid Management Registry

Nanna, M. G., Wang, T. Y., Xiang, Q., Goldberg, A. C., Robinson, J. G., Roger, V. L., Virani, S. S., Wilson, P. W. F., Louie, M. J., Koren, A., et al. (2019) · Circulation: Cardiovascular Quality and Outcomes

Lipoproteins and Cardiovascular HealthSex and Gender in Healthcare

Cited by 313